PharmaCyte Biotech (PMCB)
NASDAQ:PMCB
Holding PMCB?
Track your performance easily

PharmaCyte Biotech (PMCB) Technical Analysis

210 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
4Neutral
14Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
PharmaCyte Biotech’s (PMCB) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting PharmaCyte Biotech is a Buy.
PharmaCyte Biotech’s (PMCB) 20-Day exponential moving average is 2.03, while PharmaCyte Biotech’s (PMCB) share price is $1.981, making it a Sell.
PharmaCyte Biotech’s (PMCB) 50-Day exponential moving average is 2.07, while PharmaCyte Biotech’s (PMCB) share price is $1.981, making it a Sell.

PharmaCyte Biotech (PMCB) Pivot Points

Aug 01, 2024, 08:34 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.85
1.90
1.96
2.01
2.07
2.12
2.18
Fibonacci
1.90
1.94
1.97
2.01
2.05
2.08
2.12
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

PharmaCyte Biotech (PMCB) Moving Averages

Aug 01, 2024, 08:34 AM
Period
Simple
Exponential
MA5
2.00Sell
2.00Sell
MA10
2.01Sell
2.01Sell
MA20
2.03Sell
2.03Sell
MA50
2.07Sell
2.07Sell
MA100
2.13Sell
2.11Sell
MA200
2.15Sell
2.17Sell
PharmaCyte Biotech’s (PMCB) 10-Day exponential moving average is 2.01, while PharmaCyte Biotech’s (PMCB) share price is $1.981, making it a Sell.
PharmaCyte Biotech’s (PMCB) 100-Day exponential moving average is 2.11, while PharmaCyte Biotech’s (PMCB) share price is $1.981, making it a Sell.
PharmaCyte Biotech’s (PMCB) stock price is $1.981 and PharmaCyte Biotech’s (PMCB) 50-day simple moving average is 2.07, creating a Sell signal.
PharmaCyte Biotech’s (PMCB) stock price is $1.981 and PharmaCyte Biotech’s (PMCB) 100-day simple moving average is 2.13, creating a Sell signal.
PharmaCyte Biotech’s (PMCB) stock price is $1.981 and PharmaCyte Biotech’s (PMCB) 200-day simple moving average is 2.15, creating a Sell signal.

PharmaCyte Biotech (PMCB) Technical Indicators

Aug 01, 2024, 08:34 AM
Name
Value
Implied Action
RSI (14)
44.88
Neutral
STOCH (9,6)
28.35
Neutral
STOCHRSI (14)
14.91
Buy
MACD (12,26)
-0.02
Buy
ADX (14)
11.27
Buy
Williams %R
-88.89
Buy
CCI (14)
-94.04
Neutral
ATR (14)
0.10
-
Ultimate Oscillator
36.15
Neutral
ROC
-9.17
Sell
PharmaCyte Biotech’s (PMCB) Relative Strength Index (RSI) is 44.88, creating a Neutral signal.
PharmaCyte Biotech’s (PMCB) Trend Strength Indicator (ADX) is 11.27, creating a Buy signal.
PharmaCyte Biotech’s (PMCB) Commodity Channel Index (CCI) is -94.04, creating a Neutral signal.
PharmaCyte Biotech’s (PMCB) Price Rate of Change (ROC) is -9.17, creating a Sell signal.

FAQ

Is PMCB a Buy, Hold, or Sell?
Based on PMCB’s technical indicators, PMCB is a Sell.
    What is PMCB’s RSI (14)?
    PMCB’s RSI (14) is 44.88, which suggests PMCB is a Neutral.
      What is PMCB’s MACD?
      PMCB’s MACD is -0.02, which suggests PMCB is a Buy.
        What is PMCB’s 5-day moving average?
        PMCB’s 5-day moving average is 2.00, which suggests PMCB is a Sell.
          What is PMCB’s 20-day moving average?
          PMCB 20-day moving average is 2.03, which suggests PMCB is a Sell.
            What is PMCB’s 50-day moving average?
            PMCB’s 50-day moving average is 2.07, which suggests PMCB is a Sell.
              What is PMCB’s 200-day moving average?
              PMCB’s 200-day moving average is 2.15, which suggests PMCB is a Sell.
                What is PMCB’s Williams % R (14)?
                PMCB’s Williams % R (14) is -88.89, which suggests PMCB is a Buy.
                  What is PMCB’s CCI (14)?
                  PMCB’s CCI (14) is -94.04, which suggests PMCB is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis